VRTX is ranked highest in Validea's guru fundamental report, meeting criteria for sustained growth potential

From NASDAQ.: 2025-04-18 12:09:00

Validea’s guru fundamental report ranks VERTEX PHARMACEUTICALS INC (VRTX) highest using the P/B Growth Investor model by Partha Mohanram. The stock is a large-cap value stock in the Biotechnology & Drugs industry with a 77% rating based on fundamentals and valuation. The stock meets most criteria of the strategy, including book/market ratio, return on assets, and cash flow from operations to assets. Partha Mohanram is known for his growth model that identifies stocks with sustained future growth potential, challenging the notion that growth investing doesn’t work. Validea is an investment research service that follows strategies of investment legends like Warren Buffett and Peter Lynch.



Read more at NASDAQ.: Validea Detailed Fundamental Analysis – VRTX